ONCIMMUNE
Oncimmune (USA) LLC, founded in 2006, is an industry leader in early cancer detection. Oncimmune LLC is a wholly-owned subsidiary of Oncimmune LTD based in Nottingham, England. The company is committed to advancing early cancer detection through proprietary autoantibody assay technologies based on biological technology initially identified by John Robertson, M.D., professor of surgery at Nottingham University, England, and chief scientific officer of Oncimmune LTD. Ongoing research and developme... nt is conducted by Oncimmune under the direction of Dr. Robertson. The company’s mission is to develop early cancer detection tests to identify more than 90 percent of solid-tumor cancers, which make up 70 percent of all cancers including lung, breast, colorectal, prostate, stomach, pancreatic and ovarian. As a lab service, Oncimmune’s metro Kansas City laboratory is CLIA-certified under the Clinical Laboratory Improvements Amendment of 1988. Oncimmune LTD owns a portfolio of patents including No. 7,402,403 and No. 7,205,117.
ONCIMMUNE
Industry:
Biotechnology Commercial
Founded:
2006-01-01
Address:
Nottingham, Nottingham, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oncimmune.com
Total Employee:
101+
Status:
Active
Contact:
+44 115 823 1869
Email Addresses:
[email protected]
Total Funding:
6.82 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Basilea Pharmaceutica
Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company.
BioConsortia
BioConsortia is developing highly effective microbial consortia for increasing agricultural yields.
Cibus
Cibus specializes in developing plant and microbial platforms .
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Medicago
Medicago is a biotechnology company focused on the research, development, production, and commercialization of vaccines in Canada.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-03-19 | Protagen | Protagen acquired by Oncimmune | 4.1 M GBP |
Investors List
SBRI Healthcare
SBRI Healthcare investment in Grant - Oncimmune
Claret Capital Partners
Claret Capital Partners investment in Debt Financing - Oncimmune
Balderton Capital
Balderton Capital investment in Venture Round - Oncimmune
Official Site Inspections
http://www.oncimmune.com
- Host name: ec2-3-10-218-137.eu-west-2.compute.amazonaws.com
- IP address: 3.10.218.137
- Location: London United Kingdom
- Latitude: 51.5164
- Longitude: -0.093
- Timezone: Europe/London
- Postal: EC2V
More informations about "Oncimmune"
Oncimmune - Crunchbase Company Profile & Funding
Oncimmune (USA) LLC, founded in 2006, is an industry leader in early cancer detection. Oncimmune LLC is a wholly-owned subsidiary of Oncimmune LTD based in Nottingham, England. The company is committed to advancing early …See details»
Overview - Oncimmune
Oncimmune is a leading immunodiagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. With a partnership led …See details»
Leadership team - Oncimmune
Mike joined Oncimmune in 2017 and drove the adoption strategy for EarlyCDT Lung in the UK/Europe and Oncimmune’s move into precision medicine services. Following the sale of the …See details»
Oncimmune - Overview, News & Similar companies | ZoomInfo.com
Jul 12, 2023 View Oncimmune (www.oncimmune.com) location in Nottinghamshire, United Kingdom , revenue, industry and description. ... Oncimmune has announced that Martin …See details»
Oncimmune | Scientist.com
Oncimmune Holdings PLC Otto-Hahn-Str. 15 Dortmund, , 44227 Germany: Oncimmune LLC One Broadway, 14th Floor Cambridge, , MA, 02142 United States ... If your organization has a …See details»
Oncimmune Holdings | Lab Manager
Jul 1, 2019 Organization profile for Oncimmune Holdings on Lab Manager. Is the form not loading? If you use an ad blocker or browser privacy features, try turning them off and refresh …See details»
Oncimmune Holdings plc - AnnualReports.com
Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a …See details»
Oncimmune Locations - Contract Research Map
Otto-Hahn-Str. 15 Dortmund, 44227 Germany Oncimmune, a global leader in biomarker services is focused on antibody (autoantibody) biomarker profiling in immuno-oncology, autoimmune …See details»
Our company - Oncimmune
Understanding diseases through the lens of the human immune system. Company Overview; About ImmunoINSIGHTSâ„¢ Biomarker Discovery; Targeted Panels & ArraysSee details»
Member profile: Oncimmune | BIA
Oct 28, 2024 Oncimmune is a pioneering precision medicine company, specialising in identifying unique autoantibody signatures. Using their novel ImmunoINSIGHTSâ„¢ platform, Oncimmune …See details»
Oncimmune - teaserclub.com
Oncimmune (USA) LLC, founded in 2006, is a leader in early cancer detection, operating as a subsidiary of Oncimmune LTD based in Nottingham, England. The company specializes in …See details»
Oncimmune - VentureRadar
" Oncimmune® was founded in 2003 to commercialise technology developed in the laboratories of Professor John Robertson, a professor of surgery at Nottingham University. Research …See details»
Oncimmune Company Profile - Office Locations, Competitors
Oncimmune has 5 employees across 5 locations, $15 m in total funding, and £104 k in annual revenue in FY 2018. See insights on Oncimmune including office locations, competitors, …See details»
Oncimmune - A spin-out from Nottingham Technology Ventures
Oct 20, 2022 Oncimmune has developed a powerful new approach to the early diagnosis of primary cancer, cancer recurrence and the clinical management of cancer. The technology is …See details»
Contact us - Oncimmune
For North American enquiries. Oncimmune LLC — One Broadway, 14th Floor Cambridge, MA 02142 USASee details»
Oncimmune - Contacts, Employees, Board Members, Advisors
Oncimmune engaged in developing and commercializing its EarlyCDT platform technology.See details»
Overview - Oncimmune
Oncimmune is a leading immunodiagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Oncimmune has a diversified …See details»
Oncimmune - BIO International Convention 2025
Oncimmune. Synthesis, analytic, diagnostic services Address Germany Contact Exhibitor. Full Name * Email Address * Contact Message * Please enter the code shown above * Submit …See details»
Our Strategy - Oncimmune
ImmunoINSIGHTSâ„¢ provides expertise in the human immune system and access to our library of over 9,000 immunogenic proteins for healthcare organisations developing new and existing …See details»